Filing Details
- Accession Number:
- 0000850261-20-000029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-05 13:58:44
- Reporting Period:
- 2020-03-05
- Accepted Time:
- 2020-03-05 13:58:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 850261 | Sorrento Therapeutics Inc. | SRNE | Biological Products, (No Disgnostic Substances) (2836) | 330344842 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365035 | L Robin Smith | C/O Sorrento Therapeutics, Inc. 4955 Directors Place San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-05 | 40,000 | $2.27 | 60,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.145 to $2.42, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
